{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:27Z","timestamp":1786118787987,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/mbc.0b013e3282f2b60e","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T03:08:39Z","timestamp":1209524919000},"page":"259-262","source":"Crossref","is-referenced-by-count":12,"title":["Comparative analysis of homocysteine concentrations in patients with retinal vein occlusion versus thrombotic and atherosclerotic disorders"],"prefix":"10.1097","volume":"19","author":[{"given":"Anat","family":"Kesler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varda","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Rogowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Shimron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bracha","family":"Shainberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Ami","family":"Sela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzhak","family":"Shapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ophira","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Berliner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/bjo.49.12.626","article-title":"Occlusion of the central retinal vessels","volume":"49","author":"Hayreh","year":"1965","journal-title":"Br J Ophthalmol"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2004.06.084","article-title":"Homocysteine and retinal vein occlusion: a population-based study","volume":"139","author":"Chua","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1076\/soph.18.3.154.29809","article-title":"Hyperhomocysteinemia in central retinal vein occlusion in young adults","volume":"18","author":"Parodi","year":"2003","journal-title":"Semin Ophthalmol"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bjo.84.2.154","article-title":"Raised plasma homocysteine as a risk factor for retinal vascular occlusive disease","volume":"84","author":"Cahill","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/S0161-6420(00)00181-0","article-title":"Hyperhomo-cystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion","volume":"107","author":"Pianka","year":"2000","journal-title":"Ophthalmology"},{"key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0161-6420(01)00923-X","article-title":"Homocysteine: a risk factor for retinal venous occlusive disease","volume":"109","author":"Brown","year":"2002","journal-title":"Ophthalmology"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/eye.2000.148","article-title":"Plasma total homocysteine and retinal vascular disease","volume":"14","author":"Martin","year":"2000","journal-title":"Eye"},{"key":"R8-1-20210203","first-page":"493","article-title":"Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion","volume":"98","author":"Vine","year":"2000","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1055\/s-0037-1616130","article-title":"Thrombophilic risk factors in patients with central retinal vein occlusion","volume":"86","author":"Marcucci","year":"2001","journal-title":"Thromb Haemost"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-9560-3-13","article-title":"Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion","volume":"3","author":"Terrazzi","year":"2005","journal-title":"Thromb J"},{"key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/00001721-200210000-00007","article-title":"Central retinal vein occlusion and thrombophilia risk factors","volume":"13","author":"Adamczuk","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(01)00842-9","article-title":"Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age","volume":"109","author":"Lahey","year":"2002","journal-title":"Ophthalmology"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00417-002-0431-9","article-title":"Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion","volume":"240","author":"Weger","year":"2002","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-1-20210203","first-page":"299","article-title":"MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion","volume":"154","author":"Cruciani","year":"2003","journal-title":"Clin Ter"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000076144","article-title":"Hyperhomocysteinemia: a risk factor for retinal vein occlusion","volume":"218","author":"Yildirim","year":"2004","journal-title":"Ophthalmologica"},{"key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ophtha.2003.08.028","article-title":"Hyperhomo-cysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion","volume":"111","author":"Di Crecchio","year":"2004","journal-title":"Ophthalmology"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1167\/iovs.04-1229","article-title":"Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype","volume":"46","author":"McGimpsey","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/bjo.85.11.1313","article-title":"Plasma homocysteine, methylene tetrahydrofolate reductase C677T and factor II G20210A polymorphisms, factor VIII, and VWF in central retinal vein occlusion","volume":"85","author":"Boyd","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0002-9394(03)00571-3","article-title":"Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease","volume":"136","author":"Cahill","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1160\/TH04-11-0768","article-title":"Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors","volume":"93","author":"Janssen","year":"2005","journal-title":"Thromb Haemost"},{"key":"R21-1-20210203","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1034\/j.1600-0420.2000.078003340.x","article-title":"Hyperhomocysteinemia and the MTHFR C677T mutation in central retinal vein occlusion","volume":"78","author":"Larsson","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1167\/iovs.06-0290","article-title":"Plasma homocysteine and cysteine levels in retinal vein occlusion","volume":"47","author":"Pinna","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1034\/j.1600-0420.2000.078005523.x","article-title":"Markers of thrombophilia in retinal vein thrombosis","volume":"78","author":"Hansen","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"key":"R24-1-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00006982-200601000-00011","article-title":"Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion","volume":"26","author":"Lattanzio","year":"2006","journal-title":"Retina"},{"key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"R26-1-20210203","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/09674845.2004.11732643","article-title":"Homocysteine-induced thrombosis","volume":"61","author":"Edirisinghe","year":"2004","journal-title":"Br J Biomed Sci"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s100720200045","article-title":"Cerebral vein thrombosis and mild hyperhomocysteinemia: three new cases","volume":"23","author":"Rigamonti","year":"2002","journal-title":"Neurol Sci"},{"key":"R28-1-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.7326\/0003-4819-131-5-199909070-00003","article-title":"Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991\u20131994): population reference ranges and contribution of vitamin status to high serum concentrations","volume":"131","author":"Selhub","year":"1999","journal-title":"Ann Intern Med"},{"key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2143\/AC.61.1.2005138","article-title":"Plasma total homocysteine levels in a healthy Turkish population sample","volume":"61","author":"Taskin","year":"2006","journal-title":"Acta Cardiol"},{"key":"R30-1-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1018675624181","article-title":"Homocysteine and risk of cardiovascular disease","volume":"9","author":"Andreotti","year":"2000","journal-title":"J Thromb Thrombolysis"},{"key":"R31-1-20210203","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0248-8663(96)88394-9","article-title":"Homocysteine: relations to ischemic cardiovascular diseases","volume":"17","author":"Piolot","year":"1996","journal-title":"Rev Med Interne"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MBC.0b013e3282f2b60e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:58:53Z","timestamp":1786035533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200806000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3282f2b60e","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}